间充质干细胞来源小细胞外囊泡在DBA/2J青光眼小鼠模型中促进神经保护
该研究在遗传性DBA/2J青光眼小鼠模型中,从3月龄起每月玻璃体腔注射骨髓间充质干细胞来源小细胞外囊泡(BMSC sEV)或对照成纤维细胞来源sEV,持续9个月。结果显示BMSC sEV显著保护RBPMS阳性视网膜神经节细胞(RGC)并减少视神经变性轴突,6月龄时显著保留RGC功能,但9和12月龄无获益。
要点
- BMSC sEV玻璃体腔注射可显著保护DBA/2J小鼠RGC数量并减少视神经轴突变性。
- BMSC sEV在6月龄时显著保留RGC功能,但9和12月龄未见获益。
- 对照成纤维细胞来源sEV未显示上述神经保护效应。
核心结论
- BMSC sEV在慢性高眼压模型中为期1年具有有效神经保护作用,可保留RGC数量并防止轴突变性。
研究设计与样本
- 研究在遗传性DBA/2J青光眼小鼠模型中进行,从3月龄起每月玻璃体腔注射BMSC sEV或对照成纤维细胞来源sEV,持续9个月。
- 从3月龄起每月测量眼压,每3个月测量正暗视阈值反应;通过RBPMS全视网膜铺片染色评估RGC神经保护,通过paraphenylenediamine染色评估轴突损伤。
主要发现
- DBA/2J小鼠从6月龄开始出现慢性高眼压。
- BMSC sEV(而非成纤维细胞sEV)对RBPMS阳性RGC提供显著神经保护效应,并显著减少视神经中变性轴突的数量。
- BMSC sEV在6月龄小鼠中显著保留RGC功能,但在9和12月龄时未提供获益。
临床怎么用
- 在慢性高眼压青光眼模型中,BMSC sEV玻璃体腔重复给药可保护RGC数量并减少轴突变性。
- BMSC sEV对RGC功能的保护在6月龄时显著,但9和12月龄时未见获益,提示疗效可能随病程变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine if bone marrow-derived stem cell (BMSC) small extracellular vesicles (sEV) promote retinal ganglion cell (RGC) neuroprotection in the genetic DBA/2J mouse model of glaucoma for 12 months. METHODS: BMSC sEV and control fibroblast-derived sEV were intravitreally injected into 3-month-old DBA/2J mice once a month for 9 months. IOP and positive scotopic threshold responses were measured from 3 months: IOP was measured monthly and positive scotopic threshold responses were measured every 3 months. RGC neuroprotection was determined in wholemounts stained with RNA binding protein with multiple splicing (RBPMS), whereas axonal damage was assessed using paraphenylenediamine staining. RESULTS: As expected, DBA/2J mice developed chronic ocular hypertension beginning at 6 months. The delivery of BMSC sEV, but not fibroblast sEV, provided significant neuroprotective effects for RBPMS+ RGC while significantly reducing the number of degenerating axons seen in the optic nerve. BMSC sEV significantly preserved RGC function in 6-month-old mice, but provided no benefit at 9 and 12 months. CONCLUSIONS: BMSC sEV are an effective neuroprotective treatment in a chronic model of ocular hypertension for 1 year, preserving RGC numbers and protecting against axonal degeneration.
引用
- Mead B, Ahmed Z, Tomarev S, et al. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Neuroprotection in a Genetic DBA/2J Mouse Model of Glaucoma. Invest Ophthalmol Vis Sci. 2018. PMID: 30452601. doi:10.1167/iovs.18-25310
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。